Drugs / hCG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00808522 | Dec 2008 → Dec 2009 | breast cancer | New York Presbyterian Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00808522 ↗ |
| Modality | Protein / enzyme biologic | “recombinant hCG subcutaneous injections x 30 doses every other day lasting 60 days total.” NCT00808522 ↗ |
| Route | Subcutaneous | “recombinant hCG subcutaneous injections x 30 doses every other day lasting 60 days total.” NCT00808522 ↗ |